What many are starting to realize (that some of us complained about 2-3 years ago), is that Titan isn't even on the grid. It's not on the grid of investors (small & large), it's not on the grid of potential partners, and it's not in the grid of media/financial outlets. Reason...we have an inexperienced, weak and very low production team (To this day, I still do not know what Reiza Rayman does each and everyday. Or John Hargrove or any of the others.)
This company has lost "significant" talent in Fowler, Talarico and Leon. That does not bode well for investors or its future.
The recent raise, which barely eeked out the minimum, is an omen I believe of much bigger issues and real challenges this company now faces.
Whoever financed this most recent raise probably didn't think to ask "how much money do you need to get Ximedica back on line" which I don't think is going to happen, based how much money they need. Moreover, they should have also asked "how much money do you need to get SPORT through FDA approval? And, have you ever been on budget for any milestone?"
Would you be happy as the last round financier, buying at $.46 only to have it trading at $.34 now? Forget about the $.75 warrant in the future.
IMO, they have played a very, very bad hand and the market, their competitors and their would be partners have called their bluff.
Someone will ultimately benefit from all of their mistakes and get SPORT very, very, very cheaply. All my own personal opinion.
News 
Market Data 
Discover 
